Skip to main content
. 2016 Jul-Aug;91(4):430–435. doi: 10.1590/abd1806-4841.20164331

Table 2.

Relationship between c-Kit expression and clinicopathological, hematologic parameters

  c-Kit negative (n=10) c-Kit positive (n=22) P value
Age (year) (median [min-max]) 82.0 (59.0-88.0) 78.0 (42.0-98.0) 0.654***
Gender (n,%)     0.703**
    Male 6 (60%) 15 (68.18%)  
    Female 4 (40%) 7 (31.82%)  
Location (n,%)     0.639*
    Arm 3 (30%) 5 (22.72%)  
    Leg 6 (60%) 14 (63.64%)  
    Head and neck 1 (10%) 3 (13.64%)  
Histological stage (n,%)     0.703*
    Patch 2 (20%) 3 (13.64%)  
    Plaque 3 (30%) 7 (31.82%)  
    Nodular 5 (50%) 12 (54.54%)  
Relapse (n,%)     0.155**
    Negative 10 (100%) 17 (77.28%)  
    Positive 0 (0%) 5 (22.72%)  
Ki-67 (%) (median [min-max]) 6.0 (1.0-15.0) 5.0 (1.0-20.0) 0.886***
Mean platelet volume(fL) (median [min-max]) 7.0 (6.0-10.4) 8.4 (6.3-11.2) 0.007***
Platelets (×109/L) (median [min-max]) 244.5 (171.0-341.0) 228.5 (132.0-420.0) 0.339***
White blood cell (×109/L) (median [min-max]) 6.8 (3.5-10.6) 6.5 (4.2-11.3) 0.903***
Hemoglobin (g/dL) (median [min-max]) 13.8 (11.0-16.8) 13.6 (9.8-16.2) 0.919***
*

p value was calculated by Chi square test;

**

p value was calculated by Fisher’s exact test;

***

p value was calculated by Mann-Whitney test